STEMI and NSTEMI are two distinct pathophysiological entities: Reply [2]

European Heart Journal

Volumn 28, Issue 21, 2007, Pages 2685-2686

  Montalescot, Gilles ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VON WILLEBRAND FACTOR;

ANGIOCARDIOGRAPHY; ECHOGRAPHY; ELECTROCARDIOGRAPHY; HEART INFARCTION; HEART MUSCLE REPERFUSION; HUMAN; LETTER; PATHOPHYSIOLOGY; PATIENT CARE; PRIORITY JOURNAL; RISK FACTOR; ST SEGMENT ELEVATION;

EID: 35948989640     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehm374     Document Type: Letter

References (4)

1. Juhan-Vague I, Pyke SD, Alessi MC, Jespersen J, Haverkate F, Thomspon SG. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris: ECAT Study Group: European Concerted Action on Thrombosis and Disabilities. Circulation 1996;94:2057-2063.
2. Collet JP, Montalescot G, Vicaut E, Ankri A, Walylo F, Lesty C, Choussat R, Beygui F, Borentain M, Vignolles N, Thomas D. Acute release of plasminogen activator inhibitor-1 in st-segment elevation myocardial infarction predicts mortality. Circulation 2003;108:391-394.
3. Montalescot G, Philippe F, Ankri A, Vicaut E, Bearez E, Poulard JE, Carrie D, Flammang D, Dutoit A, Carayon A, Jardel C, Chevrot M, Bastard JP, Bigonzi F, Thomas D, for the French Investigators of the ESSENCE Trial. Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: beneficial effects of enoxaparin. Circulation 1998;98:294-299.
4. Ray KK, Morrow DA, Gibson CM, Murphy S, Antman EM, Braunwald E, and for the ENTIRE-TIMI 23 Study Group. Predictors of the rise in vWF after ST elevation myocardial infarction: implications for treatment strategies and clinical outcome: An ENTIRE-TIMI 23 substudy. Eur Heart J 2005;26:440-446.